Be Part of Something Great
Invest Directly in the Corp. or Its Subsidaries.
Read Below to Learn More About Individual Investment Opportunities.
SinoAtrix Medical
Sinoatrix Medical is a medical device company holding the IP to a novel clinical intervention that addresses hospital infection control at the patient level. Mobile Cardiac Telemetry (MCT) has become the gold standard in ambulatory cardiac arrhythmia detection — offering real-time transmission of cardiac data enabling immediate clinical intervention. MCT devices are worn continuously, frequently contact the patient’s body, and are frequently reissued across a patient population and represent an vector for patient-to-patient transfer of infectious particles.
Sinoatrix holds the intellectual property outlining a novel, high-fidelity, Type I medical device engineered to prevent soiling and contamination transfer without compromising the transmitter’s signal integrity or harming the patient.
Notice to Principal Investors: The underlying technology, engineering schematics, and prototype data constitute proprietary information. Investors and strategic partners seeking technical or financial specifics will be required to execute a formal Non-Disclosure Agreement (NDA) prior to disclosure.
Adenylis
Adenylys is a cutting-edge wellness and longevity company built to capture a defensible position in one of the fastest-growing corners of the $190–210B North American nutraceuticals market.
At the core of the Adenylis portfolio is an issued patent describing a ketogenic dietary supplement formulation capable of inducing an endogenous, nutritional ketosis within 24 hours — a breakthrough in a market of supplemnts that provide exogenous ketones or ketone precursers which have been shown clinically to have none of the benefits of a traditonal endogenous ketosis.
Click HERE to read the patent.
